Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regional intravenous guanethidine blocks in algodystrophy.

F Eulry1, D Lechevalier, B Pats

  • 1Department of Rheumatology, Hôpital Militaire BEGIN, Saint-Mande, France.

Clinical Rheumatology
|December 1, 1991
PubMed
Summary

Regional intravenous guanethidine blocks offer effective treatment for algodystrophy, particularly after other therapies fail. This study found positive results in 71% of patients, with good tolerance overall.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pruriginous vesicular eruption associated with nivolumab immunotherapy: A case of dermatitis herpetiformis.

Annales de dermatologie et de venereologie·2024
Same author

Healthcare transition from childhood to adulthood in pseudoxanthoma elasticum: Patient experience and recommendations for health practitioners.

Annales de dermatologie et de venereologie·2022
Same author

La Revue de medecine interne·2018
Same author

Gaussian Process Regression (GPR) Representation in Predictive Model Markup Language (PMML).

Smart and sustainable manufacturing systems·2017
Same author

Liver fibrosis is associated with cutaneous inflammation in the imiquimod-induced murine model of psoriasiform dermatitis.

The British journal of dermatology·2017
Same author

Cell transformation assays as predictors of human carcinogenicity.

Alternatives to laboratory animals : ATLA·2014

Area of Science:

  • Pain Management
  • Neurology
  • Pharmacology

Background:

  • Algodystrophy, also known as Complex Regional Pain Syndrome (CRPS), is a debilitating condition.
  • Previous treatments for algodystrophy often have limited success.
  • Regional intravenous guanethidine blocks are an alternative therapeutic option.

Purpose of the Study:

  • To evaluate the efficacy and safety of regional intravenous guanethidine blocks for treating algodystrophy.
  • To determine factors influencing treatment outcomes and tolerance.

Main Methods:

  • A retrospective analysis of 513 regional intravenous guanethidine blocks performed on 125 patients with algodystrophy.
  • Patients were divided into two groups: Group I (120 patients with prior treatment failure) and Group II (5 treatment-naive patients).

Related Experiment Videos

  • Outcomes and side effects were systematically recorded.

    • Main Results:

    • A positive treatment response was observed in 71% of Group I patients and 100% of Group II patients.
    • Treatment success was not significantly influenced by limb affected, sex, age, disease duration, or prior treatments.
    • Psychic disorders were associated with less frequent positive results (p < 0.02).
    • Overall tolerance was satisfactory (85.6%), with serious side effects reported in 22 cases, notably thrombophlebitis and acute ischemia.
    • Older age significantly increased the risk of intolerance (p < 0.02).

    Conclusions:

    • Regional intravenous guanethidine blocks demonstrate considerable efficacy in treating algodystrophy, especially in cases refractory to other interventions.
    • The procedure is generally well-tolerated, although age is a risk factor for adverse events.
    • Further research may explore the impact of psychological factors on treatment outcomes.